T

The Column Group

26 employees

The Column Group is a venture capital firm dedicated to developing biotechnology companies.

Investor insights

Countries invested in

united states7

Sectors invested in

Biotechnology94
Health Care74
Therapeutics61
Medical43
Pharmaceutical34
Life Science16
Biopharma15
Pharmaceuticals12
Genetics9
Medical Device8
Cancer7
Oncology6
Epigenetics6
Anitbodies6
Biologics6
Inflammation6
Clinical Trials5
Gastrointestinal Disease5
Metabolism5
Neurology5

Funding rounds participated in

$1.5M sweet spot round size

Most of their 100 investments are in rounds between $28M and $77M

Investor type

Venture Capital

Basic info

Industry

venture capital and private equity principals

Sectors

Biotechnology
Financial Services
Finance
Venture Capital

Date founded

2006

Investments made

C

Carmot Therapeutics, Inc. raised $150M on May 25, 2023

Investors: Willett Advisors LLC, TCG X, Millennium Partners, RA Capital Management, L.P. and The Column Group

S

Synthekine raised $100M on January 6, 2023

Investors: The Column Group

C

Cajal Neuroscience raised $96M on November 29, 2022

Investors: Lux Capital, Bristol-Myers Squibb, UK, Two Sigma Ventures, Dolby Family Ventures, Evotec and The Column Group

E

Escient Pharmaceuticals raised $120M on November 28, 2022

Investors: Osage University Partners (OUP), Redmile Group, Sanofi Ventures, Avego Healthcare Capital, The Eleven Fund, Partner Fund Management and The Column Group

C

Casma Therapeutics raised $46M on November 15, 2022

Investors: Eventide Management Partners, Schroders Capital, Astellas Venture Capital L.L.C., Eisai Asia, Mirae Asset MAPS Global Investments Co., Ltd, Third Rock Ventures and The Column Group

H

Hexagon Medical International raised $77M on October 11, 2022

Investors: Nextech Invest, 8VC, Two Sigma Ventures and The Column Group

C

Carmot Therapeutics, Inc. raised $160M on July 26, 2022

Investors: Willett Advisors LLC, Horizons Ventures, RA Capital Management, L.P. and The Column Group

C

Carmot Therapeutics, Inc. raised $160M on July 26, 2022

Investors: Horizons Ventures, RA Capital Management, L.P., Willett Advisors LLC and The Column Group

R

Remix Therapeutics raised $70M on May 17, 2022

Investors: Foresite Capital, Atlas Venture, Surveyor Capital, ARCH Venture Partners, Casdin Capital, LLC and The Column Group

P

Plexium raised $102M on February 23, 2022

Investors: TCG X, Lux Capital, Surveyor Capital, Pappas Capital, SoftBank Investment Advisers, M Ventures, Neotribe Ventures, RA Capital Management, L.P. and The Column Group

FAQ